Clinical Trials · NCT06935838

Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV

CompletedPhase 2Tirzepatide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
University of Hawaii
Enrollment
12
Start date
Nov 2025
Locations
1 site, United States
Primary endpoint
Change in Baseline Body Weight
View Tirzepatide compound reference